1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Advanced Balloon Catheter Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Advanced Balloon Catheter Market, by Raw Material Type
8.1.1 Nylon
8.1.1.1. Market Revenue and Forecast
8.1.2. PET (polyethylene terephthalate)
8.1.2.1. Market Revenue and Forecast
8.1.3. Polyurethane
8.1.3.1. Market Revenue and Forecast
8.1.4. Others
8.1.4.1. Market Revenue and Forecast
9.1. Advanced Balloon Catheter Market, by Application Type
9.1.1. Coronary Procedures
9.1.1.1. Market Revenue and Forecast
9.1.2. Peripheral Procedures
9.1.2.1. Market Revenue and Forecast
9.1.3. Neurovascular Procedures
9.1.3.1. Market Revenue and Forecast
9.1.4. Other Procedures
9.1.4.1. Market Revenue and Forecast
10.1. Advanced Balloon Catheter Market, by End User Type
10.1.1. Hospitals and Ambulatory Surgical Centers
10.1.1.1. Market Revenue and Forecast
10.1.2. Catheterization Laboratories
10.1.2.1. Market Revenue and Forecast
10.1.3. Others
10.1.3.1. Market Revenue and Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Raw Material Type
11.1.2. Market Revenue and Forecast, by Application Type
11.1.3. Market Revenue and Forecast, by End User Type
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Raw Material Type
11.1.4.2. Market Revenue and Forecast, by Application Type
11.1.4.3. Market Revenue and Forecast, by End User Type
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Raw Material Type
11.1.5.2. Market Revenue and Forecast, by Application Type
11.1.5.3. Market Revenue and Forecast, by End User Type
11.2. Europe
11.2.1. Market Revenue and Forecast, by Raw Material Type
11.2.2. Market Revenue and Forecast, by Application Type
11.2.3. Market Revenue and Forecast, by End User Type
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Raw Material Type
11.2.4.2. Market Revenue and Forecast, by Application Type
11.2.4.3. Market Revenue and Forecast, by End User Type
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Raw Material Type
11.2.5.2. Market Revenue and Forecast, by Application Type
11.2.5.3. Market Revenue and Forecast, by End User Type
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Raw Material Type
11.2.6.2. Market Revenue and Forecast, by Application Type
11.2.6.3. Market Revenue and Forecast, by End User Type
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Raw Material Type
11.2.7.2. Market Revenue and Forecast, by Application Type
11.2.7.3. Market Revenue and Forecast, by End User Type
11.3. APAC
11.3.1. Market Revenue and Forecast, by Raw Material Type
11.3.2. Market Revenue and Forecast, by Application Type
11.3.3. Market Revenue and Forecast, by End User Type
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Raw Material Type
11.3.4.2. Market Revenue and Forecast, by Application Type
11.3.4.3. Market Revenue and Forecast, by End User Type
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Raw Material Type
11.3.5.2. Market Revenue and Forecast, by Application Type
11.3.5.3. Market Revenue and Forecast, by End User Type
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Raw Material Type
11.3.6.2. Market Revenue and Forecast, by Application Type
11.3.6.3. Market Revenue and Forecast, by End User Type
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Raw Material Type
11.3.7.2. Market Revenue and Forecast, by Application Type
11.3.7.3. Market Revenue and Forecast, by End User Type
11.4. MEA
11.4.1. Market Revenue and Forecast, by Raw Material Type
11.4.2. Market Revenue and Forecast, by Application Type
11.4.3. Market Revenue and Forecast, by End User Type
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Raw Material Type
11.4.4.2. Market Revenue and Forecast, by Application Type
11.4.4.3. Market Revenue and Forecast, by End User Type
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Raw Material Type
11.4.5.2. Market Revenue and Forecast, by Application Type
11.4.5.3. Market Revenue and Forecast, by End User Type
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Raw Material Type
11.4.6.2. Market Revenue and Forecast, by Application Type
11.4.6.3. Market Revenue and Forecast, by End User Type
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Raw Material Type
11.4.7.2. Market Revenue and Forecast, by Application Type
11.4.7.3. Market Revenue and Forecast, by End User Type
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Raw Material Type
11.5.2. Market Revenue and Forecast, by Application Type
11.5.3. Market Revenue and Forecast, by End User Type
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Raw Material Type
11.5.4.2. Market Revenue and Forecast, by Application Type
11.5.4.3. Market Revenue and Forecast, by End User Type
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Raw Material Type
11.5.5.2. Market Revenue and Forecast, by Application Type
11.5.5.3. Market Revenue and Forecast, by End User Type
12.1. Abbott Laboratories
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Boston Scientific Corporation
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Medtronic plc
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. erumo Corporation
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. MicroPort
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Scientific Corporation
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. B. Braun Melsungen AG
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Meril Life Sciences Pvt. Ltd.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Hexacath
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Tokai Medical Products Inc.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
